Bromocryptin and epimestrol in MAP-negative secondary amenorrheas.

Abstract

18 patients, between 18 and 24 years of age, affected by normoprolactinemic secondary amenorrhea and still MAP-negative after three successive Epimestrol cycles underwent five cycles of a combined treatment (Bromocryptin and Epimestrol). Before and after the first cycle of combined treatment, in all patients FSH, LH, E2 and PRL were measured. Progesterone was evaluated three days after the thermic rise. The basal temperature was measured daily. In all the examined patients the combined treatment produced the appearance of the menstrual flow after the third therapeutical cycle. In 13 out of the 18 examined patients ovulation was observed. The hormonal dosage highlighted a clear increase in Gonadotropins and Estradiol levels.

• Authors: F Polatti
• Journal: Clinical and experimental obstetrics & gynecology (Clin Exp Obstet Gynecol) Vol. 8 Issue 4 Pg. 164-6 ( 1981) ISSN: 0390-6663 [Print] Singapore
• PMID: 6809357 (Publication Type: Journal Article)

Chemical References

• Estrenes
• Bromocriptine
• Estradiol
• Epimestrol
• Prolactin
• Luteinizing Hormone
• Follicle Stimulating Hormone

Topics

• Adolescent
• Adult
• Amenorrhea (blood, drug therapy)
• Bromocriptine (administration & dosage)
• Drug Therapy, Combination
• Epimestrol (administration & dosage)
• Estradiol (blood)
• Estrenes (administration & dosage)
• Female
• Follicle Stimulating Hormone (blood)
• Humans
• Luteinizing Hormone (blood)
• Prolactin (blood)